Active	Status	Sponsor type	Region	Phase	Filter
2 Active 3 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Anboni (unecritinib) / Sino Biopharm
NCT04412564: A Study of TQ-B3101 Capsules in Subjects With Advanced Malignant Tumor	Recruiting	2	200	RoW	TQ-B3101	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Advanced Malignant Tumor	03/21	09/21
TQ-B3101-II-02, NCT04306887: A Study of TQ-B3101 in Subjects With Relapsed or Refractory Anaplastic Large Cell Lymphoma (ALCL)	Recruiting	2	30	RoW	TQ-B3101 capsule	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Relapsed/Refractory Anaplastic Large Cell Lymphoma (ALCL)	12/22	12/22